• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Emerging Collaboration in EU Drug Pricing and Reimbursement Table 2

Article

External Link - table2.pdf

Related Content
Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Mike Ryan

Global Expansion: Q&A with Mike Ryan

Mike Hollan
November 13th 2024
Article

EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.

Vikram Anand

The Global Stage: Q&A with EVERSANA’s Vikram Anand

Mike Hollan
October 29th 2024
Article

The president of compliance services discusses the company’s recent expansion into new markets.

IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment

IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment

Don Tracy, Associate Editor
August 20th 2024
Article

In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.

Asia Embracing New Technologies for Better Healthcare

Asia Embracing New Technologies for Better Healthcare

Bruce Liu
August 13th 2024
Article

The region is moving to the forefront in integrating therapeutic innovation.

The Pharmaceutical Playbook for Asia’s Private Market

The Pharmaceutical Playbook for Asia’s Private Market

Bruce Liu
April 11th 2024
Article

Is it possible to win in Asia’s private market?